SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-18-007780
Filing Date
2018-02-13
Accepted
2018-02-13 14:05:35
Documents
1
Group Members
DAVID L. DOUGLASSDEEPIKA R. PAKIANATHAN, PH.DDELPHI BIOINVESTMENTS VIII, L.P.DELPHI MANAGEMENT PARTNERS VIII, L.L.CDOUGLAS A. ROEDERJAMES J. BOCHNOWSKI

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tv485346_sc13ga.htm SC 13G/A 113130
  Complete submission text file 0001144204-18-007780.txt   114807
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Subject) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87757 | Film No.: 18602047
SIC: 2834 Pharmaceutical Preparations

Mailing Address 160 BOVET RD, SUITE 408 SAN MATEO CA 94402
Business Address 160 BOVET RD, SUITE 408 SAN MATEO CA 94402 650-854-9650
DELPHI VENTURES VIII LP (Filed by) CIK: 0001436285 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A